SMARCA4 and neoplasm: Recent publications demonstrated the correlation between mutational status of SMARCA4 gene and loss of its protein expression in 95% of the SCCOHT cases.15 In our cohort of SCCOHT (N = 44), 88% of the tumours demonstrated complete loss of SMARCA4.